Anjarium Biosciences
Pioneering the next generation of non-viral gene therapy
Anjarium Biosciences has raised €51M across 1 funding round from 5 investors, most recently a Series A round in Sep 2021. Based in Schlieren, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Schlieren, Switzerlandwww.anjarium.com ↗
Total raised
€51M
€50,982,914
Funding rounds
1
Investors
5
distinct backers
Active since
2021-09
latest 2021-09
Funding by year
EUR raised per yearAnjarium Biosciences — funding by year — interactive chart.
Data table
| Anjarium Biosciences — funding by year | |
|---|---|
| 2021 | €51M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-09-16 | Series A | €51M | Abingworth LLP,GIMV,Omega Funds,Pfizer Ventures,Surveyor Capital | View deal → |
Related news
- Anjarium Biosciences Raises CHF 55.5 Million Series A Financingstartupticker.ch · 2021-09
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData